LifeStance Health (LFST) Cost of Revenue (2020 - 2024)

LifeStance Health has disclosed Cost of Revenue across 5 years of filings, most recently posting $212.3 million for Q3 2024.

• In Q3 2024, Cost of Revenue rose 13.72% year-over-year to $212.3 million; the TTM figure through Sep 2024 stood at $829.8 million (up 14.78% YoY), while the FY2023 annual figure was $753.6 million, up 21.05% from the prior year.
• Cost of Revenue retreated to $212.3 million in Q3 2024, from $214.5 million in the prior quarter.
• Over the last five years, Cost of Revenue for LFST reached as high as $214.5 million in Q2 2024 and fell as low as $31.3 million in Q2 2020.
• The 5-year median for Cost of Revenue is $157.3 million (2022), against an average of $151.5 million.
• Annual changes were most pronounced in 2021 — Cost of Revenue surged 249.61% — and 2024, when it climbed 12.42%.
• A 5-year view of Cost of Revenue shows it stood at $68.8 million in 2020, then jumped by 97.17% to $135.7 million in 2021, then advanced by 22.78% to $166.7 million in 2022, then climbed by 18.37% to $197.3 million in 2023, then rose by 7.6% to $212.3 million in 2024.
• According to Business Quant data, Cost of Revenue over the past three periods registered $212.3 million, $214.5 million, and $205.7 million for Q3 2024, Q2 2024, and Q1 2024 respectively.